Evidence Guest User Evidence Guest User

COVID-19: vaccine efficacy and safety

How effective are the vaccines we rely on to vaccinate the world’s population? How do they work for the elderly, children, and pregnant women? How well do they protect against infection, severe disease and death? We summarize some of the most important findings

  • 67 studies

  • 5.6 million participants

  • Data for all major vaccines currently available

  • Links to original articles

  • Regular updates

  • Expert commentary from Luc Debruyne

Read More
Conversation Guest User Conversation Guest User

Open Access is the new normal

Robert-Jan Smits
President of the Executive Board
Eindhoven University of Technology

Prof. Jean Claude Burgelman, Free University of Brussels discuss the profound and radical change COVID-19 has brought to the science-policy nexus.

Read More
Conversation Guest User Conversation Guest User

Part I – Science advice and policymaking

Sir Peter Gluckman

International Network for Government Science Advice

Sir Peter Gluckman, Chair, International Network for Government Science Advice speaks to Prof. Jean Claude Burgelman, Free University of Brussels about scientific advice and policymaking in the context of the COVID-19 response

Read More
Conversation Guest User Conversation Guest User

The power of open data

Jennifer Hansen
Microsoft

Microsoft’s Jennifer Hansen, and prof. Jean Claude Burgelman of Free University of Brussels, consider the critical challenge of increasing data literacy for data specialists, sharing the benefits of open science and open data with the public

Read More